A promising drug for neuropathic pain: identification of vesicular nucleotide transporter as a novel target of eicosapentaenoic acid
- PMID: 36627401
- PMCID: PMC10754788
- DOI: 10.1007/s11302-022-09918-7
A promising drug for neuropathic pain: identification of vesicular nucleotide transporter as a novel target of eicosapentaenoic acid
Conflict of interest statement
The authors declare no competing interests.
The authors declare no competing interests.
Similar articles
-
Vesicular nucleotide transporter is a molecular target of eicosapentaenoic acid for neuropathic and inflammatory pain treatment.Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122158119. doi: 10.1073/pnas.2122158119. Epub 2022 Jul 18. Proc Natl Acad Sci U S A. 2022. PMID: 35858418 Free PMC article.
-
Intrathecal administration of botulinum toxin type a antagonizes neuropathic pain by countering increased vesicular nucleotide transporter expression in the spinal cord of chronic constriction injury of the sciatic nerve rats.Neuropeptides. 2023 Aug;100:102346. doi: 10.1016/j.npep.2023.102346. Epub 2023 May 8. Neuropeptides. 2023. PMID: 37178626
-
Vesicular nucleotide transport: a brief history and the vesicular nucleotide transporter as a target for drug development.Curr Pharm Des. 2014;20(16):2745-9. doi: 10.2174/13816128113199990574. Curr Pharm Des. 2014. PMID: 23886392 Review.
-
Vesicular nucleotide transporter (VNUT): appearance of an actress on the stage of purinergic signaling.Purinergic Signal. 2017 Sep;13(3):387-404. doi: 10.1007/s11302-017-9568-1. Epub 2017 Jun 14. Purinergic Signal. 2017. PMID: 28616712 Free PMC article. Review.
-
Evans Blue Reduces Neuropathic Pain Behavior by Inhibiting Spinal ATP Release.Int J Mol Sci. 2019 Sep 9;20(18):4443. doi: 10.3390/ijms20184443. Int J Mol Sci. 2019. PMID: 31505901 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources